$599

FENIX Analysis: GLP-1RA Promotional Materials Post-ADA 2024

FENIX has conducted a comprehensive analysis of promotional materials obtained at ADA 2024 as well as a comparison of the respective copay card programs. In this first installment, FENIX analyzes GLP-1RA promo with separate installments to follow on CGMs and pump devices. The GLP-1RA FENIX analysis below covers Ozempic, Wegovy, Mounjaro, Zepbound, and Rybelsus.

This content is for Read Less members only.
Register
Already a member? Log in here